Table 3 Pooled performance characteristics of POCTs for HIV compared to reference assays
POCT | Pooled Sensitivity | Pooled Specificity | Prevalence Scenariosa | PPV | NPV |
|---|---|---|---|---|---|
Bioline | 98.95% | 99.89% | 5.60% | 98.16% | 99.94% |
| Â | Â | 10.60% | 99.07% | 99.88% | |
| Â | Â | 35.60% | 99.80% | 99.42% | |
| Â | Â | 40.60% | 99.84% | 99.29% | |
Chembio | 98.66% | 99.55% | 5.60% | 92.86% | 99.92% |
| Â | Â | 10.60% | 96.30% | 99.84% | |
| Â | Â | 35.60% | 99.18% | 99.26% | |
| Â | Â | 40.60% | 99.34% | 99.09% | |
Chembio MR (Micro Reader) | 98.09% | 99.54% | 5.60% | 92.67% | 99.89% |
| Â | Â | 10.60% | 96.20% | 99.77% | |
| Â | Â | 35.60% | 99.16% | 98.95% | |
| Â | Â | 40.60% | 99.32% | 98.70% |